Axonics Modulation Technologies Secures $32,600,000 Series A Financing

  • Feed Type
  • Date
    3/26/2014
  • Company Name
    Axonics Modulation Technologies
  • Mailing Address
    16411 Scientific Way Irvine, CA 92618 USA
  • Company Description
    Axonics, based in Irvine, Calif., is a privately held venture-backed pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.
  • Website
    http://www.axonicsmodulation.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $32,600,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from the financing will provide working capital to accelerate product development and fund a series of multi-center clinical studies to establish safety and efficacy of the company’s patented neuromodulation system.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy